Allogeneic transplant for older AML patients - who, when and how
Combining CLL drugs to overcome the problem of resistance
Targeted therapy of AML
Improving T-cell therapy with antigen specific T-cells
What influence do circulating myeloma plasma cells have on the treatment of multiple myeloma?